20 C
Delhi
Friday, October 23, 2020

ICMR completes second serosurvey, analysis underway in final stage

- Advertisement -

Contact tracing won’t curb corona if testing is too slow: LancetNew Delhi, Sep 20 (IANS) The Indian Council of Medical Research (ICMR) has completed the second round of the countrywide serological survey (serosurvey) to detect the prevalence of the COVID-19 disease and its analysis is underway in the final stage, the ICMR informed on Sunday.

The apex body of medical research in the country added that the ongoing study of the second serosurvey would offer a comparison with the results of the first survey that ICMR published a week ago.

The ICMR also said that it has been continuously sharing the findings of dynamic containment zones from the previous survey to the respective state authorities. “The findings of the previous survey from the dynamic containment zones were communicated to the states for further action,” it informed.

Meanwhile, the ICMR also stated that the states have also conducted their zone and city-specific surveys along with ICMR’s. “To further aid in developing state intervention plans following the ICMR survey, states have also conducted their zone/city-specific surveys,” the ICMR stated.

On Tuesday, Dr Balram Bhargava, director-general, ICMR had told during a press briefing that the results of the second serosurvey would be made public by the end of September. “The second national serosurvey is almost done. We have completed the exercise in 68 out of 70 districts, and the analysis is in progress. We should have the results by the end of September,” he had informed.

The first national serosurvey was a randomly sampled, community-based survey conducted from May 11 to June 4. The samples were collected from 700 villages and wards, which were selected from 70 districts in 21 states of the country.

The previous survey revealed that India had 6.4 million coronavirus disease (Covid-19) patients by early May.

In percentage, the national prevalence was found to be 0.73 per cent. The worst-affected were those between the age group of 18 and 45 years, as 43.3 per cent had developed antibodies against SARS-CoV-2, which causes the Covid-19 disease. While Covid-19 patients in the age group between 46 and 60 years accounted for 39.5 per cent of the sampled individuals.

The ICMR published the findings of the first survey on September 11.

Source: IANS

India Updates
India Updates is an independent news & Information website. Follow us for regular updates on News and Information.

Follow Us On

Related News

IFFI to take leaf from IPL playbook, focus on broadcasting event: Official

Panaji, Oct 22 (IANS): In the wake of Covid-19 pandemic-related restrictions, the Goa government is looking to take a leaf out of the Indian Premier...

India’s smartphone shipments hit record 50mn in Q3, Xiaomi leads

New Delhi, Oct 23 (IANS) Smartphone shipments in India hit an all-time high of 50 million units in the third quarter of this year,...

Next stimulus should focus on infrastructure building: Rajiv Kumar

New Delhi, Oct 23 (IANS): NITI Aayog Vice Chairman Rajiv Kumar on Thursday said that the next round of stimulus package from the government...

Covid-hit developers dole out festive offers for home buyers

New Delhi, Oct 22 (IANS) As the pandemic and the lockdowns brought housing demand to a halt, festivities seemed just apt for real estate...

IAVI, Merck, and Serum Institute of India to develop monoclonal antibodies for Covid

New Delhi, Oct 22 (IANS) IAVI, a non-profit scientific research organisation and Serum Institute of India announced an agreement with Merck to develop SARS-CoV-2...

Google brings India’s mini masterpieces to life with AI, AR

New Delhi, Oct 22 (IANS) Google Arts and Culture on Thursday announced it has partnered with the National Museum in New Delhi to showcase...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Trending Topics In India

Covid 19 India Updates

IAVI, Merck, and Serum Institute of India to develop monoclonal antibodies for Covid

New Delhi, Oct 22 (IANS) IAVI, a non-profit scientific research organisation and Serum Institute of India announced an agreement with Merck to develop SARS-CoV-2...

IAVI, Merck, and Serum Institute of India to develop monoclonal antibodies for Covid

New Delhi, Oct 22 (IANS) IAVI, a non-profit scientific research organisation and Serum Institute of India announced an agreement with Merck to develop SARS-CoV-2...

India in ”extremely comfortable position” in terms of oxygen availability: Health Ministry

New Delhi, Oct 20 (PTI) There has been no scarcity in oxygen supply in the last 10 months with the daily production capacity enhanced...

Virus can hit recovered Covid patients once antibodies start depleting: ICMR

New Delhi, Oct 20 (IANS) Patients who have recovered from Covid-19 can again get infected by the virus once the antibodies of the viral...

Covid to reduce profits of hospitals by 35-40% this fiscal: Crisil

Mumbai, Oct 20 (IANS) Postponement of elective surgeries, revenue loss from the highly profitable medical tourism segment, and increasing safety and sanitisation costs amid...

‘India can become global PPE hub, more R&D efforts needed’

New Delhi, Oct 18 (IANS) Within six to seven months, India has become a major manufacturer of personal protective equipment (PPE) kits and even...

Trending News In India

India’s smartphone shipments hit record 50mn in Q3, Xiaomi leads

New Delhi, Oct 23 (IANS) Smartphone shipments in India hit an all-time high of 50 million units in the third quarter of this year,...

India’s smartphone shipments hit record 50mn in Q3, Xiaomi leads

New Delhi, Oct 23 (IANS) Smartphone shipments in India hit an all-time high of 50 million units in the third quarter of this year,...

Next stimulus should focus on infrastructure building: Rajiv Kumar

New Delhi, Oct 23 (IANS): NITI Aayog Vice Chairman Rajiv Kumar on Thursday said that the next round of stimulus package from the government...

Covid-hit developers dole out festive offers for home buyers

New Delhi, Oct 22 (IANS) As the pandemic and the lockdowns brought housing demand to a halt, festivities seemed just apt for real estate...

IAVI, Merck, and Serum Institute of India to develop monoclonal antibodies for Covid

New Delhi, Oct 22 (IANS) IAVI, a non-profit scientific research organisation and Serum Institute of India announced an agreement with Merck to develop SARS-CoV-2...

Google brings India’s mini masterpieces to life with AI, AR

New Delhi, Oct 22 (IANS) Google Arts and Culture on Thursday announced it has partnered with the National Museum in New Delhi to showcase...

Trending Showbiz

IFFI to take leaf from IPL playbook, focus on broadcasting event: Official

Panaji, Oct 22 (IANS): In the wake of Covid-19 pandemic-related restrictions, the Goa government is looking to take a leaf out of the Indian Premier...

We still have much work to do in India market: Netflix

New Delhi, Oct 21 (IANS) Content streaming giant Netflix has reported slow growth in its third quarter (July-September period) despite the social distancing times,...

Vishal Bhardwaj to adapt Agatha Christie stories as film franchise

Mumbai, Oct 20 (IANS) Filmmaker Vishal Bhardwaj is developing a film franchise based on the works of famed author Agatha Christie. The series will...

‘Laxmmi Bomb’ highlights transgender community, says director Raghava Lawrence

Mumbai: The horror comedy Laxmmi Bomb, starring Akshay Kumar, is all set to release on November 9, and director Raghava Lawrence, who makes his Bollywood...

BARC India remains committed to its stakeholders

Mumbai, Oct 18 (IANS) Broadcast Audience Research Council (BARC) India on Saturday released a statement underlining the fact that the body aimed at ensuring...

Cinemas reopen: Day one sees dull start, but trade experts positive

BY NATALIA NINGTHOUJAM (IANS) Cinemas in several states including Delhi-NCR opened doors to patrons on Friday after seven months the turnout everywhere has been...

Trending Sports

Dhawan’s record ton in vain as KXIP beat DC, stay float

Dubai, Oct 20 (IANS/GloFans) A resurgent Kings XI Punjab (KXIP) on Tuesday comprehensively defeated table toppers Delhi Capitals (DC) by five wickets, despite Shikhar Dhawan's...

This IPL CSK weren’t there, says Dhoni after loss to RR

Abu Dhabi, Oct 20 (IANS) Chennai Super Kings (CSK) captain Mahendra Singh Dhoni on Monday seemed resigned to his fate after a seven-wicket defeat...

Rajasthan win comfortably, stay afloat; Chennai pushed to brink

Abu Dhabi, Oct 19 (IANS) Former champions Rajasthan Royals (RR) gave themselves a new lease of life on Monday with a convincing seven-wicket win...

KXIP crowned kings after beating MI in 2nd Super Over

Dubai, Oct 19 (IANS/GloFans) In a most dramatic contest, comprising two Super Over deciders, Kings XI Punjab (KXIP) held their nerve to eke out a...

Dhawan’s maiden ton takes DC to five-wicket win over CSK

Sharjah, Oct 17 (IANS) Shikhar Dhawan scored his maiden T20 century while Axar Patel knocked off the required 17 runs off the last over...

Latest Trending News In India

IFFI to take leaf from IPL playbook, focus on broadcasting event: Official

Panaji, Oct 22 (IANS): In the wake of Covid-19 pandemic-related restrictions, the Goa government is looking to take a leaf out of the Indian Premier...

India’s smartphone shipments hit record 50mn in Q3, Xiaomi leads

New Delhi, Oct 23 (IANS) Smartphone shipments in India hit an all-time high of 50 million units in the third quarter of this year,...

Next stimulus should focus on infrastructure building: Rajiv Kumar

New Delhi, Oct 23 (IANS): NITI Aayog Vice Chairman Rajiv Kumar on Thursday said that the next round of stimulus package from the government...

Covid-hit developers dole out festive offers for home buyers

New Delhi, Oct 22 (IANS) As the pandemic and the lockdowns brought housing demand to a halt, festivities seemed just apt for real estate...

IAVI, Merck, and Serum Institute of India to develop monoclonal antibodies for Covid

New Delhi, Oct 22 (IANS) IAVI, a non-profit scientific research organisation and Serum Institute of India announced an agreement with Merck to develop SARS-CoV-2...